IBM secures $1 billion as the U.S. supports nine quantum firms with $2 billion.

      The US Department of Commerce has entered into nine letters of intent to allocate $2.013 billion in CHIPS Act funding to quantum computing companies, in return for federal equity shares in each recipient. This announcement, made by NIST on Wednesday, represents the largest direct intervention by the US government in the quantum sector to date, following a plan first reported by the Wall Street Journal.

      IBM is the primary beneficiary with approximately $1 billion, along with a commitment to invest an additional $1 billion in a domestic quantum chip manufacturing facility. GlobalFoundries, IBM’s foundry partner, is set to receive around $375 million. Three publicly traded quantum firms—D-Wave Quantum, Rigetti Computing, and Infleqtion—are expected to receive about $100 million each, while the Silicon-spin startup Diraq is earmarked for up to $38 million.

      The unique aspect of this package is the government taking equity stakes alongside each grant, echoing the equity element from last year’s Intel CHIPS award under the Trump administration. Following the announcement, quantum stocks saw a notable increase, with publicly traded recipients climbing between 7% and 21% in premarket trading.

      The administration has positioned this funding as an industrial policy response to China. Commerce Secretary Howard Lutnick stated that the letters of intent aim to "lead the world into a new era of American innovation," which aligns with the broader White House narrative regarding critical technologies.

      NIST reports that the funding encompasses two domestic foundries and seven quantum computing companies, based on the belief that a quantum industry requires the chip-making capabilities to support it.

      For IBM, which has spent nearly a decade developing its quantum technology from a lab in Yorktown Heights to a European data center in Germany, this grant signifies validation of a long-term investment. For D-Wave, Rigetti, and Infleqtion—each of which has advocated for the significance of their technologies over the past two years—this funding is vital for their survival.

      However, the letters of intent do not define a conversion timetable. These letters do not constitute binding awards; the funds are contingent upon achieving specific milestones, and the details regarding equity terms remain undisclosed.

      NIST has framed the support as focusing on “utility-scale, fault-tolerant” quantum computers, which is where commercial viability begins to emerge. Currently, none of the recipients have reached that stage.

      Politically, this move is straightforward. Over the past three years, the US has observed China making significant progress in quantum research through state-funded laboratories, prompting the Commerce Department to respond with its own state-backed equity strategy.

      The future effectiveness of equity stakes in an industry that has yet to reach commercial viability, and whether it will yield returns or merely distribute federal risk among nine balance sheets, is a challenge that the next administration will need to address.